The first issue of Representations, a limited series exploring neurotech's evolving business frontier, produced in partnership with PL Neuro.
If BCI companies are also data companies, and data companies are AI companies, are BCI companies becoming AI companies? This opening issue argues that the real story of "NeuroAI" is the wave of business-model innovation being unleashed as neural foundation models unlock new BCI capabilities — and proprietary BCI data drives the performance of those models.
From Synchron and NVIDIA's Chiral foundation model, to Precision Neuroscience's Medtronic partnership, to Paradromics, NeuroPace, Science Corp, and Merge Labs, the piece traces how 2025 became a tipping point: BCI companies are increasingly neural-data companies, translating exclusive access into strategic and commercial value — while regulators, from UNESCO to a growing US patchwork, race to catch up.
Representations is written by Naveen Rao of Neurotech Futures, in partnership with PL Neuro.
Read the full issue: on Neurotech Futures